Analgesics (Pharmacies) - Germany

Revenue in the Analgesics market is projected to reach US$546.30m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.66%, resulting in a market volume of US$685.80m by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$6.56 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in Germany has been experiencing steady growth in recent years.

Customer preferences: In Germany, there is a strong preference for over-the-counter analgesics purchased from pharmacies. This is due to the high level of trust that German consumers have in the quality and safety of products sold in pharmacies. Additionally, pharmacies in Germany are known for their knowledgeable staff who can provide advice and guidance on the most suitable analgesics for specific needs.

Trends in the market: One of the key trends in the Analgesics market in Germany is the increasing demand for natural and herbal remedies. German consumers are becoming more health-conscious and are seeking out products that are perceived to be more natural and have fewer side effects. As a result, there has been a growing demand for analgesics made from natural ingredients, such as arnica or chamomile. Another trend in the market is the rising popularity of online pharmacies. German consumers are increasingly turning to online platforms to purchase their analgesics due to the convenience and competitive pricing offered. Online pharmacies also provide a wider range of products, allowing consumers to easily compare different brands and find the most suitable analgesic for their needs.

Local special circumstances: Germany has a strong pharmaceutical industry and is home to several major pharmaceutical companies. This has led to a high level of innovation in the analgesics market, with new products constantly being developed and introduced. German consumers have access to a wide range of analgesics, including both branded and generic options. The German healthcare system also plays a role in shaping the analgesics market. Germany has a universal healthcare system, which means that a large portion of healthcare costs are covered by health insurance. This has created a situation where consumers have relatively low out-of-pocket expenses for healthcare, including analgesics. As a result, German consumers are more likely to seek medical advice and purchase analgesics from pharmacies, rather than self-medicating with over-the-counter products.

Underlying macroeconomic factors: The German economy has been performing well in recent years, with strong GDP growth and low unemployment rates. This has contributed to increased consumer confidence and spending power, which in turn has boosted the demand for analgesics. Additionally, the aging population in Germany is driving demand for analgesics, as older individuals are more likely to experience chronic pain and require regular pain relief medication. In conclusion, the Analgesics (Pharmacies) market in Germany is experiencing steady growth due to customer preferences for pharmacy-sold products, the increasing demand for natural remedies, the rising popularity of online pharmacies, the strong pharmaceutical industry, the universal healthcare system, and the underlying macroeconomic factors.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.